The iconic rise of Viagra has long been a symbol of pharmaceutical success, however its position within the broader industry now triggers questions about potential returns . Alternative versions are undercutting patent protection , leading to worries that betting on companies closely tied to Viagra's previous influence could be a dangerous decision